Emergence and spread of artemisinin resistance calls for intensified efforts to withdraw oral artemisinin-based monotherapy from the market

A report calling for intensified action to withdraw oral artemisinin-based monotherapy from the market and to promote the use of artemisinin-based combination therapy, in order to protect against further artemisinin resistance.

← Back to previous page